These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Tau antisera recognize neurofibrillary tangles in a range of neurodegenerative disorders. Joachim CL; Morris JH; Kosik KS; Selkoe DJ Ann Neurol; 1987 Oct; 22(4):514-20. PubMed ID: 2963585 [TBL] [Abstract][Full Text] [Related]
27. Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (tau). Wood JG; Mirra SS; Pollock NJ; Binder LI Proc Natl Acad Sci U S A; 1986 Jun; 83(11):4040-3. PubMed ID: 2424015 [TBL] [Abstract][Full Text] [Related]
28. Tau protein immunoreactivity in dementia of the Alzheimer type: II. Electron microscopy and pathogenetic implications. Effects of fixation on the morphology of the Alzheimer's abnormal filaments. Papasozomenos SC Lab Invest; 1989 Mar; 60(3):375-89. PubMed ID: 2494388 [TBL] [Abstract][Full Text] [Related]
29. Antibodies to neurofibrillary tangles of Alzheimer's disease raised from human and animal neurofilament fractions. Gambetti P; Autilio-Gambetti L; Perry G; Shecket G; Crane RC Lab Invest; 1983 Oct; 49(4):430-5. PubMed ID: 6620982 [TBL] [Abstract][Full Text] [Related]
30. Isolation and characterization of cDNA clones encoding epitopes shared with Alzheimer neurofibrillary tangles. Dammerman M; Goldstein M; Yen SH; Shafit-Zagardo B J Neurosci Res; 1988; 19(1):43-51. PubMed ID: 2449545 [TBL] [Abstract][Full Text] [Related]
31. Immunological and silver staining characteristics of neurofibrillary tangles of Alzheimer type. Gambetti P; Autilio-Gambetti L; Shecket G Exp Brain Res; 1982; Suppl 5():15-9. PubMed ID: 6185356 [No Abstract] [Full Text] [Related]
32. Alzheimer's disease: exposure of neurofilament immunoreactivity in SDS-insoluble paired helical filaments. Rasool CG; Selkoe DJ Brain Res; 1984 Nov; 322(1):194-8. PubMed ID: 6083822 [TBL] [Abstract][Full Text] [Related]
33. Immunocytochemical comparison of neurofibrillary tangles in senile dementia of Alzheimer type, progressive supranuclear palsy, and postencephalitic parkinsonism. Yen SH; Horoupian DS; Terry RD Ann Neurol; 1983 Feb; 13(2):172-5. PubMed ID: 6187274 [TBL] [Abstract][Full Text] [Related]
35. Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications. Papasozomenos SC Lab Invest; 1989 Jan; 60(1):123-37. PubMed ID: 2492060 [TBL] [Abstract][Full Text] [Related]
36. Antibodies to normal and Alzheimer human brain structures from non-immunised mice of various ages. Simpson J; Milne IH; Gardner JO; Yates CM; James K; Fink G FEBS Lett; 1987 Jun; 217(1):62-4. PubMed ID: 3595845 [TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibodies to intermediate filaments in chick muscle cell cultures. Morris GE; Head LP Exp Cell Res; 1985 May; 158(1):177-91. PubMed ID: 3888643 [TBL] [Abstract][Full Text] [Related]
38. Monoclonal antibody which recognizes a common antigenic determinant on intermediate filament proteins, actin, and myosin. Franklin RM; Emmons LR; Emmons RP; Oommen A; Pink JR; Rijnbeek AM; Schnetzler M; Tuderman L; Vainio E Hybridoma; 1983; 2(3):275-85. PubMed ID: 6205979 [TBL] [Abstract][Full Text] [Related]
39. Properties of antigenic determinants that distinguish neurofibrillary tangles in progressive supranuclear palsy and Alzheimer's disease. Schmidt ML; Lee VM; Hurtig H; Trojanowski JQ Lab Invest; 1988 Oct; 59(4):460-6. PubMed ID: 2459498 [TBL] [Abstract][Full Text] [Related]
40. Alzheimer's disease: a monoclonal antibody raised against paired helical filaments. Brückner M; Bendix U; Hube M; Arendt T; Bigl V Acta Histochem Suppl; 1991; 41():143-52. PubMed ID: 1811248 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]